UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):          December 30, 2013

ACACIA RESEARCH CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware	000-26068	95-4405754
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

 

 

500 Newport Center Drive Newport Beach, California	92660
(Address of principal executive offices)	(Zip Code)

 

 

Registrant’s telephone number, including area code:       (949) 480-8300

 

Not applicable

(Former name or former address, if changed since last report.)

 

 

£	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

Item 8.01 Other Events.

 

Cell And Network Selection LLC, a subsidiary of Acacia Research Corporation, entered into a settlement and license agreement with Dell Inc.  This agreement resolved patent litigation that was pending in the United States District Court for the Eastern District of Texas, Case No. 6:13-cv-00563.

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	ACACIA RESEARCH CORPORATION
Date:  January 2, 2014	By:	/s/ Matthew Vella
		Name: Matthew Vella
		Title:   President and Chief             Executive Officer